TOC - Immune Checkpoint Inhibitors Market Size

Immune Checkpoint Inhibitors Market Report by Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin Lymphoma, and Others), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A7221

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Immune Checkpoint Inhibitors Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 CTLA-4 Inhibitor
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 PD-1 Inhibitor
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 PD-L1 Inhibitor
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacies
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Pharmacies
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Lung Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bladder Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Melanoma
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Colorectal Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Hodgkin Lymphoma
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bristol-Myers Squibb Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 GSK plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Merck & Co. Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Ono Pharmaceutical Co. Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Pfizer Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Regeneron Pharmaceuticals Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Seagen Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Immune Checkpoint Inhibitors Market: Major Drivers and Challenges
Figure 2: Global: Immune Checkpoint Inhibitors Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Immune Checkpoint Inhibitors Market: Breakup by Type (in %), 2025
Figure 5: Global: Immune Checkpoint Inhibitors Market: Breakup by Distribution Channel (in %), 2025
Figure 6: Global: Immune Checkpoint Inhibitors Market: Breakup by Application (in %), 2025
Figure 7: Global: Immune Checkpoint Inhibitors Market: Breakup by Region (in %), 2025
Figure 8: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market: Sales Value (in Million USD), 2020 & 2025
Figure 9: Global: Immune Checkpoint Inhibitors (CTLA-4 Inhibitor) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 10: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market: Sales Value (in Million USD), 2020 & 2025
Figure 11: Global: Immune Checkpoint Inhibitors (PD-1 Inhibitor) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 12: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market: Sales Value (in Million USD), 2020 & 2025
Figure 13: Global: Immune Checkpoint Inhibitors (PD-L1 Inhibitor) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 14: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 15: Global: Immune Checkpoint Inhibitors (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 16: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 17: Global: Immune Checkpoint Inhibitors (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 19: Global: Immune Checkpoint Inhibitors (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 20: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market: Sales Value (in Million USD), 2020 & 2025
Figure 21: Global: Immune Checkpoint Inhibitors (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 22: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market: Sales Value (in Million USD), 2020 & 2025
Figure 23: Global: Immune Checkpoint Inhibitors (Bladder Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 24: Global: Immune Checkpoint Inhibitors (Melanoma) Market: Sales Value (in Million USD), 2020 & 2025
Figure 25: Global: Immune Checkpoint Inhibitors (Melanoma) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 26: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market: Sales Value (in Million USD), 2020 & 2025
Figure 27: Global: Immune Checkpoint Inhibitors (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 28: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market: Sales Value (in Million USD), 2020 & 2025
Figure 29: Global: Immune Checkpoint Inhibitors (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 30: Global: Immune Checkpoint Inhibitors (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 31: Global: Immune Checkpoint Inhibitors (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 32: North America: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 33: North America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 34: United States: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 35: United States: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 36: Canada: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 37: Canada: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 38: Asia-Pacific: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 39: Asia-Pacific: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 40: China: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 41: China: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 42: Japan: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 43: Japan: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 44: India: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 45: India: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 46: South Korea: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 47: South Korea: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 48: Australia: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 49: Australia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 50: Indonesia: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 51: Indonesia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 52: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 53: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 54: Europe: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 55: Europe: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 56: Germany: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 57: Germany: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 58: France: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 59: France: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 60: United Kingdom: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 61: United Kingdom: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 62: Italy: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 63: Italy: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 64: Spain: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 65: Spain: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Russia: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 67: Russia: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 68: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 69: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 70: Latin America: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 71: Latin America: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 72: Brazil: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 73: Brazil: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 74: Mexico: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 75: Mexico: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 76: Others: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 77: Others: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Middle East and Africa: Immune Checkpoint Inhibitors Market: Sales Value (in Million USD), 2020 & 2025
Figure 79: Middle East and Africa: Immune Checkpoint Inhibitors Market: Breakup by Country (in %), 2025
Figure 80: Middle East and Africa: Immune Checkpoint Inhibitors Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Global: Immune Checkpoint Inhibitors Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Immune Checkpoint Inhibitors Industry: Value Chain Analysis
Figure 83: Global: Immune Checkpoint Inhibitors Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immune Checkpoint Inhibitors Market: Key Industry Highlights, 2025 & 2034
Table 2: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Type (in Million USD), 2026-2034
Table 3: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
Table 4: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 5: Global: Immune Checkpoint Inhibitors Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Immune Checkpoint Inhibitors Market: Competitive Structure
Table 7: Global: Immune Checkpoint Inhibitors Market: Key Players

Purchase Options Discount
Offer

Request Customization

Speak to an Analyst

Request Brochure

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.